
Opinion|Videos|June 26, 2024
Payer Coverage Considerations for New Treatments for Alzheimer Disease
Experts discuss how payers can prepare for new treatments and plan adequate coverage for patients with Alzheimer disease.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- How can plan sponsors effectively prepare for these new treatments and plan coverage in a way that ensure adequate care for patients with Alzheimer disease and availability of coverage for all patients?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
60% of US Women Face Barriers to Postpartum, Mental Health Care
4
Counseling Vitiligo Patients on Time to Repigmentation
5





